ADLI — American Medical Technologies Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for American Medical Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2003 December 31st	2004 December 31st	2005 December 31st	C2006 December 31st	2007 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10KSB	10KSB	10KSB	10KSB
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3	2.26	2.16	2.76	3.19
Cost of Revenue
Gross Profit	1.12	1.06	0.737	1.36	1.7
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	6.93	4.04	3.81	4.31	4.36
Operating Profit	-3.93	-1.79	-1.65	-1.55	-1.17
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.054	0.03	-1.54	-1.38	-0.928
Provision for Income Taxes
Net Income After Taxes	0.054	0.03	-1.54	-1.38	-0.928
Net Income Before Extraordinary Items
Net Income	0.054	0.03	-1.54	-1.38	-0.928
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	0.054	-0.058	-1.58	-1.42	-0.954
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.224	-0.007	-0.194	-0.174	-0.119
Dividends per Share